Arete Wealth Advisors’s Bio-Techne TECH Stock Holding History

Arete Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,885	Closed	-$71M	–	717
2022 Q4	$71M	Buy	+19,885	New	+$1.58M	0.01%	594

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arete Wealth Advisors's TECH Position: Q1 2023 in Review

Arete Wealth Advisors sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 19,885 shares — an estimated $71M sold.

Arete Wealth Advisors first reported a position in TECH in Q4 2022 and held it in 1 quarter. The position peaked at $71M in Q4 2022. 549 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Arete Wealth Advisors reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
Arete Wealth Advisors sold 19,885 Bio-Techne shares in Q1 2023, an estimated $71M.
Arete Wealth Advisors first reported a position in Bio-Techne in Q4 2022 and held it in 1 quarter.
Arete Wealth Advisors's Bio-Techne position peaked at $71M in Q4 2022.
549 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Arete Wealth Advisors's 13F filing for Q1 2023, filed 1 May 2023.